1.Cerebral lipiodol embolism following transcatheter arterial chemoembolization for hepatocellular carcinoma: a report of two cases and literature review.
Zhi LI ; Rui-Fang NI ; Kiran Kumar Reddy BUSIREDDY ; Yong-Hai JIN ; Xin ZHAO ; Ming-Ming LI ; Chao YANG
Chinese Medical Journal 2011;124(24):4355-4358
Cerebral lipiodol embolism (CLE) is an extremely rare complication of transcatheter arterial chemoembolization for hepatocellular carcinoma. To our knowledge, only 11 cases have been previously reported. We recently encountered two cases of CLE in our clinical work. Reviewing the 11 cases in the literature and the two cases in our report indicates that large dose lipiodol infusion and absence of particulate embolization should be avoided. The presence of a right-to-left shunt and inferior phrenic artery injection seems to increase the risk of CLE. More caution should be taken in these situations.
Carcinoma, Hepatocellular
;
therapy
;
Chemoembolization, Therapeutic
;
methods
;
Ethiodized Oil
;
therapeutic use
;
Humans
;
Liver Neoplasms
;
therapy
;
Male
;
Middle Aged
2.Percutaneous intratumoral injection with pingyangmycin lipiodol emulsion for treatment of recurrent sacrococcygeal chordomas.
Jing-yue GUAN ; Bei-bei WANG ; Chuan-jun WEI ; Yan-hao LI
Journal of Southern Medical University 2010;30(10):2366-2369
OBJECTIVETo evaluate the effectiveness and safety of fluoroscopy-guided percutaneous intratumor injection of pingyangmycin lipiodol emulsion (PLE) in the management of recurrent sacrococcygeal chordomas.
METHODSSeven patients with recurrent sacrococcygeal chordomas presenting with severe local pain with visual analogue score (VAS)≥8 received treatment sessions of fluoroscopy-guided percutaneous intratumor injection of PLE. The patients were followed up every 3 months after the last session to assess their clinical responses and observe the changes in the tumor size measured by computed tomography. The changes in the VAS, tumor necrosis and pain relief as well as the adverse events were recorded.
RESULTSA total of 22 sessions of fluoroscopy-guided percutaneous intratumoral PLE injection was performed in these cases (3 or 4 sessions in each case). The total average pingyangmycin dose delivered was 48.0 mg and the average lipiodol dose was 40.0 ml in each case. Five patients showed low fever and vomiting 48 after the injection. During the follow-up (median time of 21.7 months, range 10-26 months), all the patients showed obviously reduced tumor size and VAS, and partial remission was achieved in 6 patients and stable disease (SD) in 1 patient. None of the patients had complications during the follow-up.
CONCLUSIONFluoroscopy-guided percutaneous intratumoral injection of PLE can be effective and safe and may serve as a alternative for treatment of recurrent sacrococcygeal chordomas.
Adult ; Aged ; Bleomycin ; administration & dosage ; analogs & derivatives ; therapeutic use ; Chordoma ; drug therapy ; Emulsions ; administration & dosage ; therapeutic use ; Ethiodized Oil ; administration & dosage ; therapeutic use ; Female ; Humans ; Injections, Intralesional ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; drug therapy ; Sacrococcygeal Region ; pathology
3.Effects of transcatheter arterial chemoembolization with pingyangmycin-lipiodol emulsion on VX2 liver tumors in rabbits.
Xi LIU ; Xiao-ping LUO ; Wen-ting CAO ; Hao DENG
Chinese Journal of Hepatology 2012;20(8):611-616
To evaluate the changes induced in tumor tissue, the feeding artery, and neovascularization upon pingyangmycin-lipiodol emulsion treatment via transcatheter arterial chemoembolization (TACE) using the rabbit VX2 liver cancer model. The VX2 liver tumor model was established in 28 rabbits, and baseline tumor volume (V1, in mm3) was measured by spiral scan computed tomography (CT). Then, the rabbits were randomly divided into four groups (n = 7 each) and administered intraarterial therapies of: ultrafluid lipoidol embolization (group A); pingyangmycin (group B); pingyangmycin-lipiodol emulsion (group C); or saline (group D). All rabbits were sacrificed seven days later, and the response to therapy was determined by measuring the tumor volume (V2, in mm3), calculating the tumor growth rate, detecting expression of the vascular endothelial growth factor (VEGF) tumor biomarker, and performing histological analysis of the microvessel density (MVD) in the liver. Prior to therapy, the average V1 of the groups was statistically similar (A: 389.8+/-167.3, B: 404.1+/-184.9, C: 355.1+/-158.3, D: 378.1+/-189.0; (F = 0.257, P more than 0.05). In contrast, after therapy the average V2 of the groups was significantly different (A: 922.6+/-32.9, B: 665.9+/-99.9, C: 349.5+/-177.8, D: 1403.5+/-411.2; F = 26.23, P less than 0.05), as was the tumor growth ratio (A: 1.4, B: 0.6, C: -0.02, D: 2.7) and the mean positive ratio of VEGF (A: 57.1%, B: 42.9%, C: 28.6%, D: 100%; F = 8.407, P less than 0.05). MVD was highest in group D and lowest in group C (all, P less than 0.05). Bivariate correlation analysis revealed a positive correlation between VEGF expression and MVD (r = 0.743, P less than 0.01). Pingyangmycin exerts anti-tumor effects in the rabbit VX2 liver cancer model, but is more effective when administered as the combination therapy of pingyangmycin-lipiodol emulsion with TACE.
Animals
;
Antibiotics, Antineoplastic
;
administration & dosage
;
therapeutic use
;
Bleomycin
;
administration & dosage
;
analogs & derivatives
;
therapeutic use
;
Chemoembolization, Therapeutic
;
methods
;
Emulsions
;
Ethiodized Oil
;
administration & dosage
;
therapeutic use
;
Female
;
Iodized Oil
;
administration & dosage
;
therapeutic use
;
Liver Neoplasms, Experimental
;
blood supply
;
drug therapy
;
pathology
;
Male
;
Microvessels
;
Neoplasm Transplantation
;
Neovascularization, Pathologic
;
Rabbits
;
Random Allocation
;
Tumor Burden
;
drug effects
;
Vascular Endothelial Growth Factor A
;
metabolism
4.Value of mixed embolus transarterial chemoembolization in the treatment of hepatocellular carcinoma.
Chen-rui LI ; Wen-hao JIANG ; Xian-ming FENG ; Yan-jun GUO ; Zhong-hua SHI ; Chun-wu ZHOU
Chinese Journal of Oncology 2005;27(9):557-560
OBJECTIVETo investigate the value of transarterial chemoembolization (TACE) using mixed emboli for hepatocellular carcinoma (HCC).
METHODS188 patients with HCC were divided into two groups according to the treatment modality: 103 patients in group A treated by routine iodine embolus agent; 85 patients in group B by mixed iodine embolus agent (ultra-liquified iodinized oil + gelatin sponge + chemotherapeutic agents). The pattern of the arrested iodine deposition in the tumor, response, resectability during follow-up, pathological changes, survival and complications in the two groups were analyzed and compared.
RESULTSThe pattern of full-and-dense iodine deposition in the tumor and the response rate (CR + PR) were 59.2% and 32.0% in group A, 89.4% and 56.5% in group B. Surgical resection after TACE was possible in 5.8% (6/103) of group A versus 15.3% (13/85) of group B. Complete tumor necrosis was observed in 1.0% and 4.7% in groups A and B, respectively. 1-, 2- and 3-year actual survival rates were 57.7%, 42.8% and 8.4% in group A, and 79.8%, 55.3%, 38.5% in group B. The difference in results between the two groups was statistically significant, however, the incidence of complication in the two groups was similar.
CONCLUSIONTransarterial chemoembolization with mixed iodine emboli is more effective than with the routine iodine emboli in the treatment of bulky or nodular hepatocellular carcinoma rich in blood supply. Mixed iodine emboli is tolerable without increase in severe complications.
Antineoplastic Combined Chemotherapy Protocols ; therapeutic use ; Carcinoma, Hepatocellular ; therapy ; Catheters, Indwelling ; Chemoembolization, Therapeutic ; methods ; Ethiodized Oil ; administration & dosage ; Female ; Gelatin Sponge, Absorbable ; administration & dosage ; Hepatic Artery ; Humans ; Liver Neoplasms ; therapy ; Male
5.Transcatheter Arterial Embolization Using Ethanol in a Dialysis Patient for Contracting Enlarged Polycystic Kidneys.
Hark RIM ; Gyoo Sik JUNG ; Yeon Soon JUNG
Korean Journal of Radiology 2010;11(5):574-578
The mass effect of nephromegaly in patients with autosomal dominant polycystic kidney disease may cause pain and symptoms by compressing the alimentary tract, lungs, and heart. Conventional therapies exist to contract enlarged polycystic kidneys including surgical and interventional procedures. A surgical nephrectomy is often difficult to perform in dialysis patients due to the associated risks related to surgery. In contrast, renal transcatheter arterial embolization (TAE) with metallic coils, which is a less invasive interventional procedure, can also be utilized to contract enlarged kidneys in dialysis patients as an effective treatment. However, metallic coils present the possibility of recanalization and cost issues. Thus, we used ethanol instead of coils in renal TAE to resolve these issues. We report a dialysis patient with enlarged polycystic kidneys and poor oral intake due to abdominal distention that was successfully treated by TAE with absolute ethanol.
Aged
;
Contrast Media/administration & dosage
;
Embolization, Therapeutic/*methods
;
Ethanol/*therapeutic use
;
Ethiodized Oil/administration & dosage
;
Humans
;
Male
;
Polycystic Kidney, Autosomal Dominant/radiography/*therapy
;
*Renal Dialysis
;
Tomography, X-Ray Computed
6.Disappearance of Intrahepatic Bile Duct Hepatocellular Carcinoma after Endoscopic Retrograde Cholangiopancreatography and Transarterial Chemoinfusion: A Case Report.
Young Youn CHO ; Sang Hyub LEE ; Jae Woo LEE ; Jin Myung PARK ; Ji Kon RYU ; Yong Tae KIM ; Chang Jin YOON ; Haeryoung KIM
The Korean Journal of Gastroenterology 2014;63(5):321-324
Invasion of the bile duct by hepatocellular carcinoma (HCC), which is called intrahepatic bile duct HCC, is rare and has a poor prognosis. Early diagnosis and surgical resection is important for treatment. A 58-year-old man who underwent hepatic resection for HCC 4 years ago and received transarterial chemoembolization (TACE) 2 years after the operation for recurred HCC presented with jaundice. CT scan revealed a tumor in the common bile duct without intrahepatic lesion. Therefore, ERCP was done to perform biopsy and biliary drainage. Histological examination was compatible with hepatocellular carcinoma. However, the tumor could not be visualized at angiography and thus, only transarterial chemoinfusion was performed without embolization. The tumor had disappeared on follow-up CT scan, and the patient has been disease free for 23 months without evidence of recurrence. Herein, we report a case of intrahepatic bile duct HCC which disappeared after ERCP.
Antibiotics, Antineoplastic/therapeutic use
;
Bile Duct Neoplasms/diagnosis/pathology/secondary/*therapy
;
Bile Ducts, Intrahepatic
;
Carcinoma, Hepatocellular/*diagnosis/pathology
;
Cholangiopancreatography, Endoscopic Retrograde
;
Doxorubicin/therapeutic use
;
Embolization, Therapeutic
;
Ethiodized Oil/therapeutic use
;
Humans
;
Jaundice/etiology
;
Liver Neoplasms/*diagnosis/pathology
;
Male
;
Middle Aged
;
Neoplasm Recurrence, Local
;
Stents
;
Tomography, X-Ray Computed
;
Treatment Outcome
7.Over-expression of VEGF and MMP-9 in residual tumor cells of hepatocellular carcinoma after embolization with lipidol.
Yu-long SHI ; Tao XU ; Le-ping LI ; Xiao-ping CHEN
Journal of Huazhong University of Science and Technology (Medical Sciences) 2013;33(1):90-95
The expression and implication of vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) in residual hepatic tumor cells after lipiodol embolization were investigated. Two weeks after transplantation of VX2 tumor cells into the livers of rabbits, a xenograft model of the human hepatic neoplasm was successfully established. Forty rabbits were randomly divided into control group (n=20) and lipiodol group (n=20). For the control group, 1 mL normal saline was injected through the gastroduodenal artery, whereas 0.3 mL/kg lipiodol was applied for the lipiodol group. One week after embolization, the expression level of VEGF in the plasma was measured by using enzyme-linked immunosorbent assay (ELISA). A three-step immunohistochemical technique (ABC) was employed to detect the protein levels of VEGF and MMP-9 and the quantitative PCR for their mRNA levels was performed in the residual tumor cells. The VEGF in the plasma was significantly higher in the lipiodol group (1.42±0.29 ng/mL) than in the control group (1.12±0.21 ng/mL) (P<0.01). Moreover, the positive rate of VEGF protein in the residual tumor cells was significantly higher in the lipiodol group (62.13%±7.69%) than in the control group (53.16%±9.17%) (P<0.05). Similarly, the MMP-9 expression in the residual tumor cells was higher in the lipiodol group. The mRNA levels of VEGF (2.9313±2.4231) and MMP-9 (3.5721±1.6107) in the lipiodol group were significantly higher than those in the control group (1.5728±0.9453 and 1.7573±1.0641, respectively, P<0.05). Therefore, it was reasonable to speculate that the increased expression of VEGF and MMP-9 in residual hepatic tumor cells and tumor angiogenesis post-embolization would be responsible for the increased metastatic potentiality and invasiveness of these cells.
Animals
;
Carcinoma, Hepatocellular
;
metabolism
;
therapy
;
Cell Line, Tumor
;
Embolization, Therapeutic
;
methods
;
Ethiodized Oil
;
therapeutic use
;
Hemostatics
;
therapeutic use
;
Liver Neoplasms
;
metabolism
;
therapy
;
Matrix Metalloproteinase 9
;
metabolism
;
Neoplasm, Residual
;
metabolism
;
Rabbits
;
Treatment Outcome
;
Up-Regulation
;
drug effects
;
Vascular Endothelial Growth Factor A
;
metabolism
8.Esophageal Sinus Formation due to Cyanoacrylate Injection for Esophageal Variceal Ligation-induced Ulcer Bleeding in a Cirrhotic Patient.
Eun Kyoung KIM ; Joo Hyun SOHN ; Tae Yeob KIM ; Bae Keun KIM ; Yeon Hwa YU ; Chang Soo EUN ; Yong Cheol JEON ; Dong Soo HAN
The Korean Journal of Gastroenterology 2011;57(3):180-183
Intravariceal injection of N-butyl-2-cyanoacrylate is widely used for the hemostasis of bleeding gastric varices, but not routinely for esophageal variceal hemorrhage because of various complications such as pyrexia, bacteremia, deep ulceration, and pulmonary embolization. We report a rare case of esophageal sinus formation after cyanoacrylate obliteration therapy for uncontrolled bleeding from post-endoscopic variceal ligation (EVL) ulcer. A 50-year-old man with alcoholic liver cirrhosis presented with hematemesis. Emergent esophagogastroscopy revealed bleeding from large esophageal varices with ruptured erosion, and bleeding was initially controlled by EVL, but rebleeding from the post-EVL ulcer occurred at 17th day later. Although we tried again EVL and the injections of 5% ethanolamine oleate at paraesophageal varices, bleeding was not controlled. Therefore, we administered 1 mL cyanoacrylate diluted with lipiodol and bleeding was controlled. Three months after the endoscopic therapy, follow-up endoscopy showed medium to large-sized esophageal varices and sinus at lower esophagus. Barium esophagography revealed an outpouching in esophageal wall and endoscopic ultrasonography demonstrated an ostium with sinus. It is noteworthy that esophageal sinus can be developed as a rare late complication of endoscopic cyanoacrylate obliteration therapy.
Cyanoacrylates/administration & dosage/*adverse effects
;
*Embolization, Therapeutic
;
Endoscopy, Digestive System
;
Esophageal and Gastric Varices/complications/*diagnosis/therapy
;
Esophagus/radiography/ultrasonography
;
Ethiodized Oil/therapeutic use
;
Gastrointestinal Hemorrhage/surgery/*therapy
;
Humans
;
Ligation
;
Liver Cirrhosis, Alcoholic/*complications/diagnosis
;
Male
;
Middle Aged
;
Tissue Adhesives/administration & dosage/*adverse effects
;
Ulcer/*complications